Matthew A. Gregory

1.6k total citations
35 papers, 1.2k citations indexed

About

Matthew A. Gregory is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Matthew A. Gregory has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Matthew A. Gregory's work include Microbial Natural Products and Biosynthesis (9 papers), Signaling Pathways in Disease (9 papers) and Biochemical and Molecular Research (5 papers). Matthew A. Gregory is often cited by papers focused on Microbial Natural Products and Biosynthesis (9 papers), Signaling Pathways in Disease (9 papers) and Biochemical and Molecular Research (5 papers). Matthew A. Gregory collaborates with scholars based in United Kingdom, United States and Sweden. Matthew A. Gregory's co-authors include Margaret C. M. Smith, Rob Till, Barrie Wilkinson, Rose Sheridan, Steven J. Moss, Hrvoje Petković, Peter F. Leadlay, Sabine Gaisser, Steven E. Wilson and Robin Burns and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Matthew A. Gregory

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew A. Gregory United Kingdom 19 877 566 209 153 145 35 1.2k
Stefan Schmelz Germany 15 541 0.6× 101 0.2× 119 0.6× 51 0.3× 91 0.6× 30 791
Mark Welch United States 18 1.3k 1.4× 153 0.3× 69 0.3× 108 0.7× 154 1.1× 19 1.4k
Bryan Julien United States 15 818 0.9× 581 1.0× 165 0.8× 201 1.3× 186 1.3× 21 1.2k
Kai-Fa Huang Taiwan 21 689 0.8× 84 0.1× 103 0.5× 86 0.6× 68 0.5× 56 1.1k
Suman Pradhan United States 21 790 0.9× 39 0.1× 78 0.4× 165 1.1× 46 0.3× 32 1.2k
M. Moche Sweden 20 1.1k 1.2× 116 0.2× 68 0.3× 151 1.0× 42 0.3× 32 1.6k
Yuan Feng United States 3 712 0.8× 46 0.1× 35 0.2× 48 0.3× 58 0.4× 4 984
Gianni Chinali Italy 21 1.1k 1.2× 117 0.2× 97 0.5× 77 0.5× 39 0.3× 49 1.4k
G. Cohen Israel 17 820 0.9× 258 0.5× 83 0.4× 105 0.7× 85 0.6× 21 1.3k
Azmiri Sultana Canada 11 459 0.5× 177 0.3× 58 0.3× 13 0.1× 51 0.4× 15 710

Countries citing papers authored by Matthew A. Gregory

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Gregory more than expected).

Fields of papers citing papers by Matthew A. Gregory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Gregory. The network helps show where Matthew A. Gregory may publish in the future.

Co-authorship network of co-authors of Matthew A. Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Gregory. A scholar is included among the top collaborators of Matthew A. Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Gregory. Matthew A. Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sibley, Adam, Christopher J. Still, Matthew A. Gregory, et al.. (2025). Extreme Heatwave Causes Immediate, Widespread Mortality of Forest Canopy Foliage, Highlighting Modes of Forest Sensitivity to Extreme Heat. Global Change Biology. 31(11). e70571–e70571.
2.
Kennedy, Robert E., Janet L. Ohmann, Matthew A. Gregory, et al.. (2017). An empirical, integrated forest biomass monitoring system. Environmental Research Letters. 13(2). 25004–25004. 66 indexed citations
3.
Kiakos, Konstantinos, Vijay Satam, Pravin Patil, et al.. (2016). Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1860(5). 617–629. 7 indexed citations
4.
Netzker, Tina, et al.. (2016). An Efficient Method To Generate Gene Deletion Mutants of the Rapamycin-Producing Bacterium Streptomyces iranensis HM 35. Applied and Environmental Microbiology. 82(12). 3481–3492. 13 indexed citations
5.
Hansson, Magnus J., Steven J. Moss, Michael Bobardt, et al.. (2015). Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection. Chemistry & Biology. 22(2). 285–292. 27 indexed citations
6.
Smith, Margaret C. M., Roger W. Hendrix, Rebekah M. Dedrick, et al.. (2013). Evolutionary Relationships among Actinophages and a Putative Adaptation for Growth in Streptomyces spp. Journal of Bacteriology. 195(21). 4924–4935. 27 indexed citations
7.
Satam, Vijay, Pravin Patil, Balaji Babu, et al.. (2013). Hx-amides: DNA sequence recognition by the fluorescent Hx (p-anisylbenzimidazole)•pyrrole and Hx•imidazole pairings. Bioorganic & Medicinal Chemistry Letters. 23(6). 1699–1702. 5 indexed citations
8.
Gregory, Matthew A., et al.. (2013). Synthesis, cytotoxicity, and structure–activity insight of NH- and N-methyl-3,5-bis-(arylidenyl)-4-piperidones. Medicinal Chemistry Research. 22(11). 5588–5597. 13 indexed citations
9.
Kendrew, Steven G., Hrvoje Petković, Sabine Gaisser, et al.. (2012). Recombinant strains for the enhanced production of bioengineered rapalogs. Metabolic Engineering. 15. 167–173. 11 indexed citations
10.
Bobardt, Michael, Steven J. Moss, Udayan Chatterji, et al.. (2011). Activity of Novel Cyclophilin Inhibitors based on the Polyketide, Sanglifehrin A, against HIV. Antiviral Research. 90(2). A29–A29. 1 indexed citations
11.
Woolard, Jeanette, W. D. Vousden, Stephen J. Moss, et al.. (2010). Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science. 2(2). 273–278. 24 indexed citations
12.
Sheridan, Rose, Matthew A. Gregory, Hrvoje Petković, et al.. (2006). Brain-selective mTOR inhibitors as potential therapeutics for glioblastoma multiforme. Cancer Research. 66. 1052–1052. 1 indexed citations
13.
Gregory, Matthew A., Hui Hong, Rachel E. Lill, et al.. (2006). Rapamycin biosynthesis: elucidation of gene product function. Organic & Biomolecular Chemistry. 4(19). 3565–3565. 40 indexed citations
14.
Wilkinson, Barrie, Matthew A. Gregory, Steven J. Moss, et al.. (2006). Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain. Bioorganic & Medicinal Chemistry Letters. 16(22). 5814–5817. 37 indexed citations
15.
Gregory, Matthew A., Hrvoje Petković, Rachel E. Lill, et al.. (2005). Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis. Angewandte Chemie International Edition. 44(30). 4757–4760. 84 indexed citations
16.
Gregory, Matthew A., Hrvoje Petković, Rachel E. Lill, et al.. (2005). Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis. Angewandte Chemie. 117(30). 4835–4838. 16 indexed citations
17.
Gregory, Matthew A., Sabine Gaisser, Rachel E. Lill, et al.. (2004). Isolation and Characterization of Pre‐rapamycin, the First Macrocyclic Intermediate in the Biosynthesis of the Immunosuppressant Rapamycin by S. hygroscopicus. Angewandte Chemie International Edition. 43(19). 2551–2553. 36 indexed citations
18.
Gregory, Matthew A., Sabine Gaisser, Rachel E. Lill, et al.. (2004). Isolation and Characterization of Pre‐rapamycin, the First Macrocyclic Intermediate in the Biosynthesis of the Immunosuppressant Rapamycin by S. hygroscopicus. Angewandte Chemie. 116(19). 2605–2607. 2 indexed citations
19.
Gregory, Matthew A., Rob Till, & Margaret C. M. Smith. (2003). Integration Site forStreptomycesPhage φBT1 and Development of Site-Specific Integrating Vectors. Journal of Bacteriology. 185(17). 5320–5323. 232 indexed citations
20.
Smith, Margaret C. M., Robin Burns, Steven E. Wilson, & Matthew A. Gregory. (1999). The complete genome sequence of the Streptomyces temperate phage  C31: evolutionary relationships to other viruses. Nucleic Acids Research. 27(10). 2145–2155. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026